Portfolio

Education Background

October
2001
MBChB, Medicine & Surgery

Makerere University College of Health Sciences,
School of Medicine, Uganda

October
2010
M. Sc., Public Health and Epidemiology

London School of Hygiene and Tropical
Medicine, United Kingdom

November
2021
PhD, Public Health

University of Witwatersrand, South Africa

Current Appointments

Director of Research

Makerere University-Johns Hopkins University Research (MU-JHU) Collaboration, Kampala, Uganda

Senior Research Scientist/ Investigator

Makerere University-Johns Hopkins University Research (MU-JHU) Collaboration, Kampala, Uganda

Distance Learning Tutor/ Examiner, Clinical Trials Unit

London School of Hygiene and Tropical Medicine, London, United Kingdom

Honorary lecturer

Makerere University College of Health Sciences, School of Public Health, Kampala, Uganda

Honours & Awards

Dr. Flavia Matovu Has been recognised and awarded for her work in the medical field

The Phoebe Leboy Professional Development Award

American Society for Bone and Mineral Research (ASBMR)  2024

Most prestigious postgraduate (PhD) award 2021

5 Pillars Extraordinary Accomplishments Award

’5 Pillars’’ On Spot Award

From the MU-JHU Executive Committee in recognition of outstanding achievements as an independent investigator.

CARTA PhD Scholarship

Commonwealth Scholar,M.Sc. in Epidemiology

Best Student in Internal Medicine

Gilead Global Public Health Award in Viral Hepatitis.

Presentations at Recent International Conferences

• Recovery of Bone Mass in Women on Depo-Provera and TDF based ART Switched to B/F/TAF INSPIRE Gilead Phase 4 HIV Research Forum on Monday 22nd July in Munich. Oral abstract presentation

• Impact of concurrent initiation of Depo-Provera and TDF-containing ART on bone loss in young women, 25th International AIDS Conference (AIDS 2024) held in Munich, Germany, July 22nd to 26th ,2024, poster presentation.

• Impact of concurrent initiation of Depo-Provera and TDF-containing ART on bone loss in young women, 25th INTEREST conference 2024 held in Cotonou, Benin, Germany, 14-17 May 2024, mini oral abstract/poster presentation.

• Body composition changes among DMPA and non-hormonal contraceptive users on TDF based ART switched to B/F/TAF, 30th Conference on Retroviruses and Opportunistic Infections (CROI 2023) held in Denver, Colorado, USA, March 3 – 6, 2024, poster presentation.

• Use of Intramuscular depot medroxyprogesterone acetate worsens degradation of bone micro architecture in young women living with HIV initiating TDF-containing ART, 23rd International Workshop on Long-term Complications of HIV and SARS-CoV-2, held in Washington DC, December 14 – 15, 2023, oral presentation.

• Bone Mineral Density Changes in Postpartum Mothers Living with HIV on ART, the Asia-Pacific AIDS & Co-Infections Conference (APACC) 2023, Singapore, June 8 – 10, 2023, poster presentation.

• Recovery of Bone Mass in Women on Depo-Provera and TDF based ART Switched to B/F/TAF, 30th Conference on Retroviruses and Opportunistic Infections (CROI 2023) held at the new Summit Convention Center in Seattle, Washington, USA, February 19 to 22, 2023, poster presentation.

• Use of the recent infection testing algorithm to estimate background HIV incidence in micro-epidemic areas within Uganda, 24th International AIDS Conference (AIDS 2022) held in Montreal, Canada, July 29 to August 2, 2022. Satellite oral and poster presentation

• Impact of Maternal HIV/HBV Co-infection on Pregnancy and Infant Outcomes, 28th Conference on Retroviruses and Opportunistic Infections (CROI 2022), February 12 -16, 2022, held in Denver, Colorado, USA, poster presentation.

• Depot Medroxyprogesterone Acetate is Associated with Lower Bone Mass and Higher Central Fat in Young Women on Tenofovir Disoproxil Fumarate-Containing ART, 23rd International Workshop on Long-term Complications of HIV and SARS-CoV-2, December 6 – 9, 2021, virtual oral presentation.

• Infant Outcomes in HIV/Hepatitis B co-infected Women Initiating Anti-Retroviral Therapy Regimens in the Promoting Maternal and Infant Survival Everywhere Study (PROMISE), American Association for the Study of Liver Diseases, Nov 13 – 16, 2020 Virtual poster presentation. 

• F Kiweewa Matovu et al Depo-Provera Worsens Bone Loss with Tenofovir Initiation, 23rd International AIDS Conference (AIDS 2020: Virtual), July 6-10, 2020, virtual Oral presentation.

• Bone Mineral Density Changes in Young African Women on Tenofovir Disoproxil Fumarate Antiretroviral Therapy and Non-hormonal Contraception, 17th European AIDS Conference (EACS), Basel, Switzerland, November 6 – 9, 2019, poster presentation.

• Bone mineral density changes in young African women initiating tenofovir disoproxil fumarate based antiretroviral therapy and non-hormonal contraception, 21st International Workshop on Adverse Drug Reactions and Co-Morbidities in HIV, Basel Switzerland, November 5, 2019, oral presentation.

• Bone Mineral Density Changes Post Tenofovir Treatment Initiation in Antiretroviral-Naïve HIV-Infected African Women on Non-hormonal Contraception, 10th International AIDS Society Conference on HIV Science (IAS 2019), 21-24 July 2019, Mexico City, Mexico, poster presentation.

• Bone Mineral Density in a Cohort of Young Adult Women Using Depo-Provera and Tenofovir, Kampala, Uganda, 19th International Workshop on Adverse Drug Reactions and Co-Morbidities in HIV, Milan, Italy, October 23 – 25, 2017, Oral presentation.

• Acquisition of Sexually Transmitted Infections among Women Using a Variety of Contraceptive Options: A Prospective Study among High-Risk African Women, 9th International AIDS Society Conference on HIV Science (IAS 2017), Paris, France, July 23 – 26, 2017, Oral presentation.

• Acquisition of Gonorrhea and Chlamydia Infections among Oral Contraceptive and Depot Medroxyprogesterone Acetate Users in MTN-003 (VOICE), Microbicide trials network regional meeting, held in Cape Town, October 4 – 8, 2015, Oral presentation.

• Prevalent and Incident Gonorrhea and Chlamydia Infections among Oral –Cont Contraceptive and Depot Medroxyprogesterone Acetate Users in MTN-003 (VOICE), HIV Research for Prevention 2014: AIDS Vaccine, Microbicide and ARV-based Prevention Science (HIV R4P) held in Cape Town, South Africa October 28 – 31, 2014 poster presentation

• Hematologic and Chemistry Normal Laboratory Values among Healthy Ugandan Women Screened for a Pre-Exposure Prophylaxis Trial: the MTN-003(VOICE) Study’ presented as a poster at HIV Research for Prevention 2014: AIDS Vaccine, Microbicide and ARV-based Prevention Science (HIV R4P) held in Cape Town, South Africa 28 – 31 October

• Efficacy of Peer Counselors & Nurses in Supporting Adherence to HAART among HIV-1 infected Patients at The Mulago Hospital PMTCT Clinic: A Randomized Non-Inferiority Interventional Trial, F Matovu et al, presented as a theme discussion at CROI 2011, Boston, USA, and the 12th Annual Scientific Conference for the Uganda Society for Health Scientists, June2011

RECENT WORKSHOPS/ CONFERENCES/ SHORT COURSES FACILITATED

Dec 14 – 15, 2023

25th International Workshop on Long-term Complications of HIV and SARSCoV-2 panelist, PLENARY – Multimorbidity and Aging (roundatable)

Dec 13, 2023

Facilitator/ grants reviewer, Career Development Studio held at The National Institute of Allergy and Infectious Diseases (NIAID), 5600 Fishers Lane, Rockville, MD 20852, United States

Nov 9, 2023

DXA Uganda Medical and Dental Practitioners Webinar, Virtual presentation on ‘’Body Mass & Body Composition: The role of DXA Imaging’’

Dec 6 – 9, 2022

Oral abstract session chair, 24th International Workshop on Long-term Complications of HIV and SARS-CoV-2

Dec 6 – 9, 2021

Oral abstract session chair, 24th International Workshop on Long-term Complications of HIV and SARS-CoV-2

February 3, 2021

HIV R4P virtual meeting, panelist, ADVANCING NOVEL HIV PREVENTION STRATEGIES, TOGETHER: A SCIENTIFIC AND COMMUNITY EXCHANGE, Wednesday February 3, 2021

March 4- 7, 2019

Conference on Retroviruses and Opportunistic Infections (CROI), Seattle Washington. Oral Abstract Session moderator, STRANGE BEDFELLOWS: STIs, CONTRACEPTION, AND TRIALS OF HIV TESTING, Tuesday Mar 05, 2019

October 1 – 6, 2018

2018 CARTA Graduate Workshop, Safari Park Hotel & Casino, Nairobi, Kenya

July 16 – 20, 2018

The SAMSON (the Sub-Saharan African MuSculOskeletal Network)Strategic Proposal Writing Workshop, Durban, South Africa

July 2 – 6, 2018

Principles and Practices of Epidemiology, Makerere University, Uganda

May 7 – 11, 2018

TUYIGA G11 Proposal Writing & Grant Application Submission for NIH Workshop,
MU- JHU Research Collaboration, Kampala, Uganda

April 4 – 7, 2018

PROJECT PROPOSAL WRITING: How to Write Winning Proposals That Are Captivating, Persuasive and Fundable in 4 Days, organized by Success Africa Makerere University, Uganda

August 7-18, 2017

Clinical and Community Trials and Applied Biostatistics II

July 23 – 26, 2017

9th International AIDS Society Conference on HIV Science (IAS 2017), Paris, Italy.

Tue July 25, 2017

International AIDS Society Conference on HIV Science (IAS 2017), Paris, Italy. Oral Abstract Session moderator, UPDATES FROM PREP CLINICAL TRIALS

Oct 10-15, 2016

Regional short course in health systems research, Makerere University, Uganda

🔥 Are you interested in learning about HIV Treatment and Bone Health?

 Please register for free at this link